Moderna’s KP.2 vaccine was up to eight times more effective at protecting mice against JN variants than its XBB.1.5 vaccine. When compared to its now-available XBB vaccine, Pfizer’s KP.2 COVID ...

COVID-19 is the illness caused by the novel coronavirus, SARS-CoV-2. While many people with COVID-19 get mild symptoms, others can become seriously ill.Several vaccines have been developed to ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

"We’ve connected with the Vero Beach pharmacy team and reminded them of current CDC guidance regarding clinically ...

The deployment of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) and other vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in a significant decrease ...

In the Overcoming Covid-19 investigation, we recently reported the interim findings of high effectiveness (93%) for the BNT162b2 vaccine against Covid-19 hospitalization among adolescents between ...

Health authorities and scientists say they are now racing to study BA.2.86, a new strain of the virus that causes COVID-19, after the highly mutated variant was spotted spreading in multiple ...

COVID-19-related hospitalizations occurred in six bivalent vaccine recipients and 297 individuals who did not receive it. The crude event rate was 0.27 per 100,000 person-days at risk, and the ...

People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...

Cuba said on Thursday its two-shot Soberana 2 vaccine, delivered with a booster called Soberana Plus, had proven 91.2% effective in late stage clinical trials against the coronavirus, following ...

When scientists began seeking a vaccine for the SARS-CoV-2 coronavirus in early 2020, they were careful not to promise quick success. The fastest any vaccine had previously been developed, from ...